Elsevier journal removes two 42-year-old papers on cesium as a cancer treatment

An Elsevier journal has removed two papers on a discredited alternative treatment for cancer nearly half a century after they were published, after researchers found a quarter of patients in case reports of the therapy, cesium chloride, died from taking the substance. 

Some alternative medicine advocates marketed cesium chloride as a cancer treatment in the 1980s and 1990s, although the risks and ineffectiveness of the therapy have been known for decades. In 2018, the U.S. Food and Drug Administration issued a warning about “significant safety risks” associated with the salt. 

Marcel van der Heyden, a professor at the University Medical Center Utrecht in The Netherlands, told Retraction Watch he and his students came across the articles while writing a review of case reports on the use of cesium. Although the therapy was supported online and in health books, he said, all pointed to two 1984 papers in Pharmacology Biochemistry and Behavior: “Cesium therapy in cancer patients” by Hellfried Sartori and “The high pH therapy for cancer tests on mice and humans” by Aubrey Keith Brewer.

Continue reading Elsevier journal removes two 42-year-old papers on cesium as a cancer treatment

“Not suitable in this context” means retraction in pharmacology journal

pbbPharmacology Biochemistry and Behavior had a curious retraction notice in September that we’re just now getting around to, but we think you’ll find it to have been worth the wait.

The article, “Interaction of Somatostatin Receptor-2 and Neuropeptide Y Receptor-1 in mice dorsal root ganglion neurons on the Pinch-Nerve injury model,” came from a group in Harbin, China, and Frieburg, Germany, and was published in April 2013.

According to the notice: Continue reading “Not suitable in this context” means retraction in pharmacology journal